| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |